2023
DOI: 10.1101/2023.01.26.525375
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments

Abstract: Blocking the import of nutrients essential for cancer cell proliferation represents a therapeutic opportunity, but it is unclear which transporters to target. Here, we report a CRISPRi/a screening platform to systematically interrogate the contribution of specific nutrient transporters to support cancer cell proliferation in environments ranging from standard culture media to tumor models. We applied this platform to identify the transporters of amino acids in leukemia cells and found that amino acid transport… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 67 publications
0
10
0
Order By: Relevance
“…The design and construction of transporter CRISPRi and CRISPRa sgRNA libraries has been reported elsewhere 40 . The multiplicity of infection (MOI) of lentiviral supernatant produced from each library was determined by titration onto MCF7 CRISPRi and CRISPRa cell lines and quantification of the percentage of puromycin resistant cells.…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…The design and construction of transporter CRISPRi and CRISPRa sgRNA libraries has been reported elsewhere 40 . The multiplicity of infection (MOI) of lentiviral supernatant produced from each library was determined by titration onto MCF7 CRISPRi and CRISPRa cell lines and quantification of the percentage of puromycin resistant cells.…”
Section: Methodsmentioning
confidence: 99%
“…To prepare complete RPMI medium with amino acids present at physiological levels screens (RPMI-PAA), base medium lacking amino acids was prepared as above, except that 965 mL deionized H 2 O was used. To that, amino acids were added to their concentration in human plasma using the same stock solutions as for RPMI above and as previously described 40 . All media were preheated and equilibrated to 37 °C/5% CO 2 before use.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations